These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 20845608

  • 21. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO, Fischer DH.
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [Abstract] [Full Text] [Related]

  • 22. Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.
    Schulz H, Pels H, Schmidt-Wolf I, Zeelen U, Germing U, Engert A.
    Haematologica; 2004 Jun; 89(6):753-4. PubMed ID: 15194546
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.
    Wong WW, Schild SE, Halyard MY, Schomberg PJ.
    J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
    Mazhar D, Stebbing J, Bower M.
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
    [Abstract] [Full Text] [Related]

  • 27. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
    O'Brien PC, Roos DE, Liew KH, Trotter GE, Barton MB, Walker QJ, Poulsen MG, Olver IN.
    Med J Aust; 1996 Oct 21; 165(8):424-7. PubMed ID: 8913243
    [Abstract] [Full Text] [Related]

  • 28. Intracerebral hemorrhage as a late complication after CNS treatment of childhood lymphoma.
    Claviez A, Neubauer B, Link J, Schneppenheim R.
    Klin Padiatr; 1998 Oct 21; 210(6):406-8. PubMed ID: 9871896
    [Abstract] [Full Text] [Related]

  • 29. [Combined modality therapy for malignant lymphoma of the primary central nervous system: a preliminary report of a new chemotherapeutic regimen with "PEACE"].
    Keyaki A, Nabeshima S, Waga S.
    No Shinkei Geka; 1999 Nov 21; 27(11):999-1005. PubMed ID: 10565043
    [Abstract] [Full Text] [Related]

  • 30. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 21; 30(3):200-2. PubMed ID: 18756936
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY, Li YX, Zhao LJ, Gao YH, Liu XF, Gu DZ, Qian TN, Yu ZH.
    Zhonghua Zhong Liu Za Zhi; 2004 Jul 21; 26(7):425-9. PubMed ID: 15355649
    [Abstract] [Full Text] [Related]

  • 34. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
    Singhal D, Witham TF, Germanwala A, Flickinger JC, Schiff D, Kondziolka D.
    Can J Neurol Sci; 2002 May 21; 29(2):147-53. PubMed ID: 12035835
    [Abstract] [Full Text] [Related]

  • 35. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
    Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y.
    Cancer; 2002 Aug 01; 95(3):576-80. PubMed ID: 12209750
    [Abstract] [Full Text] [Related]

  • 36. Flying solo: chemotherapy without radiation for primary CNS lymphoma.
    Batchelor TT.
    J Clin Oncol; 2013 Sep 01; 31(25):3051-3. PubMed ID: 23715569
    [No Abstract] [Full Text] [Related]

  • 37. Primary CNS lymphoma: 5-year survival in relation to dosage of methotrexate and radiation.
    Meyer MA.
    Ann Hematol; 2004 Aug 01; 83(8):549. PubMed ID: 15052370
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
    Alnahhas I, Malkin M.
    Neurology; 2015 Dec 15; 85(24):e187-9. PubMed ID: 26668244
    [No Abstract] [Full Text] [Related]

  • 40. Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.
    Houillier C, Choquet S, Touitou V, Martin-Duverneuil N, Navarro S, Mokhtari K, Soussain C, Hoang-Xuan K.
    Neurology; 2015 Jan 20; 84(3):325-6. PubMed ID: 25527263
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.